ecogacrinnews2

August 17, 2021
Green tea catechin pills

Now Enrolling: EA8184 for Prostate Cancer

This phase II study is testing the effects and safety of green tea catechins (GTC) as a chemopreventive agent
August 17, 2021
Doctor talking with patient

Now Enrolling: EAA171/OPTIMUM for Myeloma

This randomized phase III trial aims to determine if the addition of ixazomib to lenalidomide improves overall survival in patients with multiple myeloma
August 17, 2021
Patient getting imaging

EA2185 Pancreatic Cyst Surveillance Study: Amendment #2 Highlights

This study is evaluating two different screening strategies for non-cancerous pancreatic cysts; recently activated amendment #2 expands the eligibility criteria
August 17, 2021
Montefiore exterior shot

Institution Spotlight: Montefiore Health System and Albert Einstein Cancer Center

A Standing Main Member of ECOG-ACRIN since 1972
July 7, 2021
Colorectal cancer awareness ribbon

Now Enrolling: EA2201 for Rectal Adenocarcinoma

This phase II study will test the effect of nivolumab plus ipilimumab, with short-course radiation, for the neoadjuvant treatment of patients with low-lying, locally advanced MSI-H/dMMR rectal cancer
July 7, 2021
Older woman walking with doctor

Trial Spotlight: Efrat Dotan on the GIANT Study for Older Adults with Pancreatic Cancer

The GIANT trial (EA2186) is the first randomized clinical trial to focus on vulnerable older adults with treatment-naïve metastatic pancreatic cancer who are not candidates for standard therapy
December 14, 2020
Dr. O'Dwyer and Dr. Schnall

From the Co-Chairs, November/December 2020

Lessons learned from our first virtual Group Meeting and a new leadership appointment
December 14, 2020
Clipboard and laptop

Now Enrolling: ECOG-ACRIN Opened Five New Trials in October

The five phase III trials span different cancer types: prostate, leukemia, anal, lung, and myeloma
December 14, 2020
Man holding throat

Reopened Trial: Jennifer Eads, MD on Study EA2174 for Esophageal and Gastroesophageal Cancer

EA2174 will evaluate the role of perioperative immunotherapy for patients with esophageal or gastroesophageal junction adenocarcinoma
December 14, 2020
Bonnie Ky, MD headshot

ECOG-ACRIN Names University of Pennsylvania’s Bonnie Ky As Its Young Investigator of the Year

Already among the most influential thought leaders in cardio-oncology, Dr. Ky is the first in this field to receive the Group’s highest research distinction
December 14, 2020
News in Brief

News in Brief, November/December 2020

October 23, 2020
Young Investigator headshots

Meet the 2020 Young Investigator Symposium Presenters

The purpose of the Symposium is to introduce young investigators to ECOG-ACRIN and provide them with a forum to present their research in a formal manner and obtain feedback